Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000020

Chief Medical Officer sold 1,708 shares at $21.64 ($36,961)

  • Chief Medical Officer acquired 5,750 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-20 Exercise or conversion : show line 1 in the form 10b5-1 +5,750 33,619 D
2024-01-24 Sale : show line 2 in the form 10b5-1 −1,708 $21.64 $36,961 31,911 D
Open-market sales · 1,708 sh · avg $21.64 · $36,961

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-20 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −5,750 0 D
Loading xslF345X05/wk-form4_1706131453.xml…